Cleared Traditional

K924718 - SHROUDED NEEDLE DEVICES

K924718 is an FDA 510(k) clearance for SHROUDED NEEDLE DEVICES, manufactured by Imed Corp.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 270-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1993
Decision
270d
Days
Class 2
Risk

K924718 is an FDA 510(k) clearance for the SHROUDED NEEDLE DEVICES. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Imed Corp. (San Diego, US). The FDA issued a Cleared decision on June 18, 1993 after a review of 270 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Imed Corp. devices

FDA 510(k) Submission Details - K924718

510(k) Number K924718 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 21, 1992
Decision Date June 18, 1993
Days to Decision 270 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
141d slower than avg
Panel avg: 129d · This submission: 270d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 644
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K924718.
REPLACEMENT CAP
K930855 · Douglas Medical Products Corp. · Jul 1993
DOUGLAS MEDICAL PRODUCTS, INC. VENTED SPIKE ADAPT
K926184 · Douglas Medical Products Corp. · Jul 1993
BAXTER SOLUTION ADMINISTRATION SETS
K924721 · Baxter Healthcare Corp · Jul 1993
INTERLINK(TM) INJECTION SITE
K925126 · Baxter Healthcare Corp · Jun 1993
AVI(TM) MODEL 232 STANDARD IV ADMINISTRATION SET
K924207 · 3M Health Care, Ltd. · May 1993
INTERLINK SYSTEM - T-CONNECTOR EXTENSION SET
K921899 · Baxter Healthcare Corp · Apr 1993